Hudson Bay Capital Management LP Intellia Therapeutics, Inc. Transaction History

Hudson Bay Capital Management LP

$24.1 Billion
Q4 2024

A detailed history of Hudson Bay Capital Management LP transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Hudson Bay Capital Management LP holds 512,300 shares of NTLA stock, worth $6.23 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

512,300

Previous 335,000 52.93%

Holding current value

$6.23 Million

Previous $6.88 Million 13.23%

% of portfolio

0.02%

Previous 0.03%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$11.41 - $21.09 $2.02 Million - $3.74 Million	177,300 Added 52.93%	512,300 $5.97 Million
Q3 2024 Nov 13, 2024	BUY	$19.72 - $27.36 $1.18 Million - $1.64 Million	60,000 Added 21.82%	335,000 $6.88 Million
Q2 2024 Aug 14, 2024	BUY	$20.02 - $27.22 $554,554 - $753,994	27,700 Added 11.2%	275,000 $6.15 Million
Q1 2024 May 15, 2024	BUY	$23.82 - $32.8 $233,436 - $321,440	9,800 Added 4.13%	247,300 $6.8 Million
Q4 2023 Feb 14, 2024	BUY	$23.16 - $32.34 $1.21 Million - $1.69 Million	52,300 Added 28.24%	237,500 $7.24 Million
Q3 2023 Nov 14, 2023	BUY	$31.62 - $45.78 $796,824 - $1.15 Million	25,200 Added 15.75%	185,200 $5.86 Million
Q2 2023 Aug 14, 2023	SELL	$34.58 - $46.03 $1.38 Million - $1.84 Million	-40,000 Reduced 20.0%	160,000 $6.52 Million
Q1 2023 May 15, 2023	SELL	$33.3 - $44.82 $269,730 - $363,042	-8,100 Reduced 3.89%	200,000 $7.45 Million
Q4 2022 Feb 14, 2023	BUY	$33.21 - $62.69 $6.41 Million - $12.1 Million	193,100 Added 1287.33%	208,100 $7.26 Million
Q3 2022 Nov 14, 2022	SELL	$53.92 - $71.7 $2.98 Million - $3.97 Million	-55,300 Reduced 78.66%	15,000 $839,000
Q2 2022 Aug 12, 2022	BUY	$38.49 - $76.21 $227,091 - $449,638	5,900 Added 9.16%	70,300 $3.64 Million
Q1 2022 May 16, 2022	BUY	$58.27 - $118.99 $2 Million - $4.09 Million	34,400 Added 114.67%	64,400 $4.68 Million
Q4 2021 Feb 14, 2022	BUY	$100.76 - $138.36 $1.26 Million - $1.73 Million	12,500 Added 71.43%	30,000 $3.55 Million
Q3 2021 Nov 15, 2021	BUY	$132.37 - $176.78 $2.32 Million - $3.09 Million	17,500 New	17,500 $2.35 Million

Others Institutions Holding NTLA

# of Institutions

336

Shares Held

96.1M

Call Options Held

1.06M

Put Options Held

863K

View Full List

About Intellia Therapeutics, Inc.

Ticker NTLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,011,800
Market Cap $925M
Description
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...

More about NTLA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hudson Bay Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Hudson Bay Capital Management LP with notifications on news.

Account

Hudson Bay Capital Management LP Intellia Therapeutics, Inc. Transaction History